Skip to main content
. 2016 Jul 1;5(3):353–361. doi: 10.1007/s40121-016-0119-9

Fig. 2.

Fig. 2

Primary and secondary endpoints by classification and treatment (mITT population). CI confidence interval, ECE early clinical evaluation (48–72 h from treatment initiation), IPAT inpatient parenteral antibiotic therapy, mITT modified intent-to-treat, OPAT outpatient parenteral antibiotic therapy, ORI oritavancin, PTE post-therapy evaluation (7–14 days after the end of therapy), VAN vancomycin